Stocks and Investing Stocks and Investing
Thu, July 20, 2023

Yigal Nochomovitz Maintained (APLS) at Strong Buy with Decreased Target to $80 on, Jul 20th, 2023


Published on 2024-10-28 04:57:16 - WOPRAI, Yigal Nochomovitz
  Print publication without navigation


Yigal Nochomovitz of Citigroup, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Decreased Target from $106 to $80 on, Jul 20th, 2023.

Yigal has made no other calls on APLS in the last 4 months.



There are 6 other peers that have a rating on APLS. Out of the 6 peers that are also analyzing APLS, 1 agrees with Yigal's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $81 on, Friday, May 5th, 2023


These are the ratings of the 5 analyists that currently disagree with Yigal


  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $100 on, Tuesday, July 18th, 2023
  • Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $108 on, Friday, May 12th, 2023
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $110 on, Friday, May 5th, 2023
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $156 on, Friday, May 5th, 2023
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $141 on, Friday, April 14th, 2023

Contributing Sources